Innovative Technology TriAltus Bioscience has developed the CLīM™ affinity tag system, which enables high-yield, single-step enzyme purification, offering cost-effective and high-quality solutions. This innovation presents opportunities to partner with organizations seeking efficient enzyme production technologies.

Recent Product Launches The company launched the CLīM™ Affinity Tag System in late 2021 and previously introduced the Activated Im7 affinity chromatography resin in 2019. These recent innovations indicate an active product development pipeline targeting the biotech research sector.

Growing Market Presence With annual revenues estimated between $1 million and $10 million and ongoing product innovations, TriAltus is positioned for growth in the competitive enzyme and protein purification market, providing opportunities to expand its customer base.

Funding and Development Having secured approximately $1.6 million in funding, TriAltus is likely investing in further R&D and scaling efforts, making it a promising partner for suppliers of biotech materials, reagents, and related products.

Niche Market Focus Operating with a small team of 2-10 employees, TriAltus specializes in high-value biotech research tools. Collaborations with larger biotech and research organizations could unlock sales opportunities in advanced protein purification technologies.